Propranolol therapy in patients undergoing myocardial revascularization

Area of Science:

• Cardiology
• Pharmacology

Background:

• Propranolol is a beta-blocker commonly used for cardiovascular conditions.
• Preoperative medication management is crucial for patients undergoing cardiac surgery.

Purpose of the Study:

• To investigate the association between preoperative propranolol administration and complications during myocardial revascularization.
• To determine optimal strategies for propranolol withdrawal in patients undergoing cardiac surgery.

Main Methods:

• Retrospective review of 185 consecutive patients undergoing myocardial revascularization.
• Analysis of preoperative propranolol use and intraoperative/postoperative complications.

Main Results:

• Tachycardia and hypertension were more common in patients not taking propranolol or who stopped it >48 hours pre-op.
• No significant difference in post-bypass hypotension based on propranolol withdrawal timing.
• Operative mortality was similar across groups (3-4%).
• Five patients experienced acute myocardial infarction within 48 hours of routine preoperative propranolol withdrawal.

Conclusions:

• Complete preoperative withdrawal of propranolol may precipitate acute myocardial infarction in patients with unstable angina.
• Gradual withdrawal over 48 hours is recommended.
• Reduced doses can be safely administered up to 10 hours pre-operation if needed, with careful patient selection.